EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction

Jade Dunot, Carine Gandin, Marin Truchi, Giulia Pirro, Sébastien Moreno, Agathe Launay, Benjamin Azoulay, Hugo Landra, Sandy Ma Yishan, Luc Buée, Kevin Lebrigand, Paula A Pousinha und 5 weitere

Acta Neuropathologica · 03.06.2026 · 151 (1)

DOI: 10.1007/s00401-026-03033-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 03.06.2026. Verfasst von Jade Dunot und 16 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France. jade@ad6d.net. Hauptthemen laut MEDLINE: Alzheimer Disease, Synapses, Amyloid beta-Protein Precursor, Hippocampus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, Fondation Vaincre Alzheimer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD), the leading cause of dementia, is characterized by early synaptic dysfunction that precedes overt cognitive decline. While amyloid-β and Tau remain central to AD pathogenesis, molecular triggers of synapse weakening remain unclear. Here, we investigated AETA, a novel brain-secreted peptide derived from amyloid precursor protein (APP), as a potential mediator of synapse dysfunction in AD. We previously identified AETA as a unique modulator of NMDA receptor activity in the healthy brain; however, its role in AD etiology was yet to be explored. Post-mortem analyses of human hippocampal and prefrontal cortex tissues revealed significantly elevated AETA levels in AD patients, particularly in females. To further explore the contribution of AETA to AD synaptic pathology, we analyzed a new mouse model, the AETA-m mouse, exhibiting chronically increased brain AETA expression. Hippocampi of female AETA-m mice displayed an increase in the number of astrocyte and microglia, but no overt neuroinflammation. RNA sequencing of female AETA-m hippocampi revealed alterations in synaptic gene expression that closely paralleled those observed in vulnerable human AD brain regions, most notably in the hippocampus. These two phenotypes were absent in males. Functionally, hippocampal neurons from AETA-m mice displayed impaired NMDA receptor signaling, dendritic spine loss, and memory deficits especially in females, mirroring early AD-associated synaptic dysfunction. Together, these findings identify AETA as a novel key contributor of synaptic vulnerability in AD and associated memory processing, especially in females. Targeting AETA signaling may therefore offer new therapeutic avenues for preventing or mitigating synaptic and cognitive decline in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSynapsesAmyloid beta-Protein PrecursorHippocampusAnimalsFemaleHumansMaleMiceMice, TransgenicDisease Models, AnimalMice, Inbred C57BLNeuronsBrainMicroglia

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyloid precursor proteinHippocampusMemorySynapse

Substanzen

Amyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Université Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France. jade@ad6d.net.
  • Université Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.
  • Univ. Lille, INSERM, CHU Lille, UMR-S1172 LilNCog-Lille Neuroscience and Cognition, Lille, France.
  • Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, Munich, Germany.
  • Université Côte d'Azur, CNRS, INSERM, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France. marie@ipmc.cnrs.fr.

Förderung

  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale
  • Fondation Vaincre Alzheimer
  • French Association France Alzheimer
  • French Fondation Alzheimer
  • Flag ERA JTC 2019

Zitieren

APA

Dunot, J., Gandin, C., Truchi, M., Pirro, G., Moreno, S., Launay, A., Azoulay, B., Landra, H., Yishan, S. M., Buée, L., Lebrigand, K., Pousinha, P. A., Blum, D., Mari, B., Bethus, I., Willem, M., & Marie, H. (2026). AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction. Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03033-2

Vancouver

Dunot J, Gandin C, Truchi M, Pirro G, Moreno S, Launay A, et al. AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction. Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03033-2

BibTeX
@article{Dunot2026,
  author = {Dunot, Jade and Gandin, Carine and Truchi, Marin and Pirro, Giulia and Moreno, Sébastien and Launay, Agathe and Azoulay, Benjamin and Landra, Hugo and Yishan, Sandy Ma and Buée, Luc and Lebrigand, Kevin and Pousinha, Paula A and Blum, David and Mari, Bernard and Bethus, Ingrid and Willem, Michael and Marie, Hélène},
  title = {AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {151},
  number = {1},
  doi = {10.1007/s00401-026-03033-2}
}
Kostenlos starten →